Skip to main content
. 2018 Sep 10;13:5287–5299. doi: 10.2147/IJN.S177256

Figure 8.

Figure 8

Evaluation of antibacterial activity of nanofibrous scaffolds.

Notes: (1) Filter paper control, (2) PCL, (3) FLS, (4) DLS against Staphylococcus aureus (A), Pseudomonas aeruginosa (B), and Escherichia coli (C) and evaluation of the inhibition zones for filter paper control, PCL, FLS, and DLS against S. aureus, P. aeruginosa, and E. coli (D). *The difference in mean is significant (P<0.05) with respect to control. #The difference in mean is significant (P<0.05) with respect to PCL.

Abbreviations: DLS, double layer nanofibrous scaffolds; FLS, first layer of scaffolds; PCL, polycaprolactone.